Evidence supporting the use of: Salix babylonica
For the health condition: Blood Clots (prevention of)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Salix babylonica (weeping willow) contains salicin, a precursor to salicylic acid, which is similar in structure and function to acetylsalicylic acid (aspirin). Aspirin is well-known for its antiplatelet (blood-thinning) effects and is widely used for the prevention of blood clots. Traditional use of willow bark as an analgesic and anti-inflammatory dates back thousands of years, but its use specifically for blood clot prevention is based on its salicylate content and the pharmacological actions of related compounds.

There is some scientific rationale for considering willow bark as potentially supportive for blood clot prevention due to its salicylate content. However, the concentration of salicin in Salix babylonica bark is variable and generally lower than the standardized dose of aspirin used in clinical settings for antiplatelet therapy. Clinical studies directly evaluating Salix babylonica (or willow bark extracts) for the explicit prevention of blood clots in humans are lacking. Most supporting evidence is extrapolated from the known effects of aspirin, rather than direct clinical trials with willow bark itself.

Therefore, while there is a plausible scientific mechanism and historical use of willow bark for related purposes, direct evidence supporting its efficacy and safety for blood clot prevention is limited, and it should not be used as a substitute for medically-approved antiplatelet therapy.

More about Salix babylonica
More about Blood Clots (prevention of)

Products containing Salix babylonica

We currently have no products on Vitabase that contain this ingredient.